DalsnaFinance › IPOs › Oric Pharmaceuticals Inc › IPO
Oric Pharmaceuticals, Inc. completed its initial public offering on NASDAQ on April 24, 2020, pricing at $16.00 a share.
| Ticker | ORIC |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | April 24, 2020 |
| Offering price | $16.00 |
| Shares offered | 7,500,000 |
| Total raised | $120M |
Oric Pharmaceuticals, Inc. sold 7,500,000 shares at $16.00 each on NASDAQ. Multiplied out, that is $120 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $120 million total recorded for the deal.
Oric Pharmaceuticals, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Oric Pharmaceuticals, Inc.. This page is general information, not investment advice.